Home › Employers › Boston BioProducts
Boston BioProducts: H-1B salaries and sponsorship
Boston BioProducts filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $82,302.
Does Boston BioProducts sponsor H-1B visas?
Boston BioProducts filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Jun 10, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Process Development Engineer | 3 | $74,000 |
| Quality Operations Manager | 1 | $158,309 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 2 | $74,000 |
| FY2026 | 2 | $124,457 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Quality Operations Manager | $158,309–$165,000 Level IV | Milford, MA | Jun 10, 2026 | Oct 1, 2026 | Certified |
| Process Development Engineer | $90,605–$125,000 Level I | Milford, MA | Feb 17, 2026 | Jul 1, 2026 | Certified |
| Process Development Engineer | $74,000–$94,000 Level I | Milford, MA | Jun 21, 2023 | Jul 1, 2023 | Certified |
| Process Development Engineer | $74,000–$94,000 Level I | Milford, MA | May 22, 2023 | Jun 5, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).